These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32456131)

  • 21. Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation†.
    Miao D; Giassetti MI; Ciccarelli M; Lopez-Biladeau B; Oatley JM
    Biol Reprod; 2019 Jul; 101(1):177-187. PubMed ID: 31095680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development.
    Vélez-Reyes GL; Koes N; Ryu JH; Kaufmann G; Berner M; Weg MT; Wolf NK; Rathe SK; Ratner N; Moriarity BS; Largaespada DA
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
    Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
    Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.
    Wang D; Mou H; Li S; Li Y; Hough S; Tran K; Li J; Yin H; Anderson DG; Sontheimer EJ; Weng Z; Gao G; Xue W
    Hum Gene Ther; 2015 Jul; 26(7):432-42. PubMed ID: 26086867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
    Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
    Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 for cancer research and therapy.
    Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
    Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells.
    Guo Y; Bao C; Ma D; Cao Y; Li Y; Xie Z; Li S
    ACS Synth Biol; 2019 Mar; 8(3):482-490. PubMed ID: 30762338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 32. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.
    Miller DT; Cortés-Ciriano I; Pillay N; Hirbe AC; Snuderl M; Bui MM; Piculell K; Al-Ibraheemi A; Dickson BC; Hart J; Jones K; Jordan JT; Kim RH; Lindsay D; Nishida Y; Ullrich NJ; Wang X; Park PJ; Flanagan AM
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32252413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
    Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
    Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creation of knock out and knock in mice by CRISPR/Cas9 to validate candidate genes for human male infertility, interest, difficulties and feasibility.
    Kherraf ZE; Conne B; Amiri-Yekta A; Kent MC; Coutton C; Escoffier J; Nef S; Arnoult C; Ray PF
    Mol Cell Endocrinol; 2018 Jun; 468():70-80. PubMed ID: 29522859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing.
    Pankowicz FP; Barzi M; Kim KH; Legras X; Martins CS; Wooton-Kee CR; Lagor WR; Marini JC; Elsea SH; Bissig-Choisat B; Moore DD; Bissig KD
    Gastroenterology; 2018 Dec; 155(6):1967-1970.e6. PubMed ID: 30170115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
    Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
    J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas9-mediated therapeutic editing of
    Jo DH; Song DW; Cho CS; Kim UG; Lee KJ; Lee K; Park SW; Kim D; Kim JH; Kim JS; Kim S; Kim JH; Lee JM
    Sci Adv; 2019 Oct; 5(10):eaax1210. PubMed ID: 31692906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.